Latest Business Development News

Prescient Therapeutics (ASX:PTX) has opened a $7 million Share Purchase Plan at a significant discount to advance its lead cancer therapy PTX-100 beyond a pivotal Dose Optimisation Committee review in late 2026.

Prescient Therapeutics launches a $7 million Share Purchase Plan at an 18.8% discount to fund advancement of its PTX-100 cancer therapy beyond a key 2026 Dose Optimisation Committee review.

Jcurve Solutions (ASX:JCS) posted a significant financial turnaround in FY2026, with revenue climbing 16.3% to $13.28 million and normalised EBITDA more than doubling to $1.88 million, underpinned by disciplined cost control and recurring revenue growth.

XPON Technologies (ASX: XPN) posted a $1.1 million positive EBITDA in FY26 on 38% revenue growth, shedding Alpha Digital and selling its Google Marketing business to focus on its Wondaris AI platform.

Electro Optic Systems (ASX:EOS) reported a record first half in 2026 with revenue soaring 283% to A$168.8 million, driven by the MARSS acquisition and expanding defence contracts. The order book jumped 84% to A$846 million, underpinning a bullish outlook amid a global defence spending surge.

Acusensus posted a 45% jump in FY26 revenue to $86.2 million, driven by major contract wins in New Zealand and the US, alongside robust domestic expansions. Despite a widened net loss due to a $16 million litigation settlement, adjusted EBITDA climbed 49%, reflecting operational momentum and strategic investments.

Oakridge International Limited has reversed its fortunes with a 42% revenue increase to $3.45 million and a return to profitability in FY2026, driven by healthcare technology sales and strategic platform enhancements.

RooLife Group (ASX:RLG) has completed a strategic acquisition to bolster its renewable energy division, acquiring project origination and delivery assets in the battery storage and hybrid power market. The deal is scrip-based, with most consideration contingent on future contract milestones.

Prescient Therapeutics cut its net loss by 4.4% to $7 million in FY26 while expanding its PTX-100 Phase 2a trial across three continents and securing key regulatory designations in Europe and the US.

Australis Oil & Gas has locked in a major US-listed partner to fund a US$46.25 million drilling program in the Tuscaloosa Marine Shale, with its first carried well slated for late 2026.

PlaySide Studios reversed a prior-year loss with a 13% revenue increase to $54.9 million and a 144% jump in net profit to $5.4 million, driven by strong Original IP sales and a strategic cost restructure.

Magnum Mining has completed nearly 7,000m of drilling at its Piracanjuba North rare earth project, expanding its footprint ahead of a planned November resource estimate, while assay results from Palmares await interpretation amid a strategic portfolio review.